Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Japan is expected to grow at a CAGR of 6.4%, driven by an aging population, high awareness of diabetes management options, and the growing adoption of GLP-1 therapies as part of a comprehensive diabetes care approach
Product Features Contains Semaglutide GLP-1 receptor agonist Prefilled pen with 9.6 mg/3ml concentration Once-weekly dosing for improved convenience Supports blood sugar control and weight management User-friendly injection device for easy administration How It Helps Enhances insulin secretion and controls blood glucose Reduces appetite and promotes weight loss Lowers HbA1c levels effectively Helps prevent long-term diabetes complications Reviews There are no reviews yet.
Take health both seriously and playfully In beauty, integrated health takes the shape of a multi-step skincare routine
Popular method of non-surgical blepharoplasty to correct hooded eye/drooping of the upper eyelid
Bork, vice president of intellectual property at Novo Nordisk
US$ 25.52
US$ 21.06
US$ 28.34
